Pirkko Santavuori (1933 – 2004) was a Finnish paediatric neurologist.
Professor Pirkko Santavuori was one of the founders of Finnish paediatric neurology. She was an internationally recognized child neurologist, well known in the field of myology for her pioneering work on muscle–eye–brain (MEB) disease.
She is eponymously remembered for her 1973 description and work on Santavuori disease [later renamed infantile neuronal ceroid lipofuscinosis (INCL)]. Santavuori also described the Finnish variant of the Jansky-Bielchowsky disease; progressive ataxia with ophthalmoplegia [infantile onset spinocerebellar ataxia (IOSCA)]; and Muscle-Eye-Brain disease (MEB).
- 1933 – Born April 29 in Helsinki, Finland
- 1960 – Graduated medicine from the Medical School of Helsinki University
- 1961-1996 – Worked at the Children’s Hospital in Helsinki. Her interest in paediatric neurology was aroused during residency and she was one of the first to specialise in the field in the early 1970s
- 1974 – Defended her PhD thesis in medicine and surgery
- 1996 – Co-chair of the Sixth International Congress on Neuronal Ceroid-Lipofuscinoses in Gustavelund, Finland
- 1996 – Retired
- 1997 – Duodecim’s Konrad ReijoWaara Award from the Finnish Medical Society
- 2004 – Died February 6
Santavuori disease (1973)
[Also known as: Infantile neuronal ceroid lipofuscinosis (INCL); Santavuori-Haltia disease; Haltia-Santavuori syndrome; Hagberg-Santavuori disease; Santavuori disease]
Infantile form of neuronal ceroid lipofuscinosis, which becomes clinically apparent between 6 and 18 months of age and presents as a rapidly progressive mental and psychomotor deterioration with hypotonia, microcephaly, convulsive disorders, blindness, and ataxia.
In 1868, Hagberg et al described infantile progressive encephalopathy with disturbed poly-unsaturated fat metabolism in a child of unrelated Finnish parents. The disorder was characterized by mental retardation, loss of speech, minor motor seizures, regression of motor development, and ataxia. Histology of the brain revealed derangement of cortical cytoarchitecture, severe degeneration of white matter, and deposits of granular material suggesting free fatty acids and unsaturated fatty acids.
In 1973, Santavuori, Haltia et al described the clinical, morphological and biochemical aspects of the infantile type of neuronal ceroid-lipofuscinosis. Morphologic findings included severe neuronal destruction with massive accumulations of phagocytes, often binucleated, and unusually hypertrophic fibrillary astrocytes in the cerebral cortex. The fatty acid pattern of serum lecithin showed an increase of arachidonic acid and corresponding decrease of linoleic acid.
Santavuori et al further reported that infantile-onset CLN is clinically homogeneous in the Finnish population. After normal development, visual failure, speech and motor deterioration, and seizures appeared between the ages of 6 and 24 months. They identified at least 55 cases of the same abnormality in Finland.
Baumann and Markesbery described the first American cases in 1982: 3 cases in 2 unrelated families showing signs of early developmental deterioration, retinal blindness, microcephaly, and seizures. They also identified inclusion material in circulating leukocytes characteristic of Santavuori disease.
Muscle–Eye–Brain (MEB) disease (1977)
In 1977, Santavuori described a group of severely retarded, floppy infants with poor vision and elevated creatinine kinase. She termed the condition Muscle–Eye–Brain (MEB) disease. A model for muscular dystrophies caused by defective O-glycosylation of proteins.
- Santavuori P, Haltia M, Rapola J, Raitta C. Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients. J Neurol Sci. 1973;18(3):257-267.
- Haltia M, Rapola J, Santavuori P, Keränen A. Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies. J Neurol Sci. 1973;18(3):269-285.
- Santavuori P, Haltia M, Rapola J. Infantile type of so-called neuronal ceroid-lipofuscinosis. Dev Med Child Neurol. 1974;16(5):644-653.
- Santavuori P, Leisti J, Kruus S. Muscle, Eye and Brain Disease: A New Syndrome. Neuropediatrics, 1977; 8(S-01): 553–553.
- Santavuori P, Somer H, Sainio K, et al. Muscle-eye-brain disease (MEB). Brain Dev. 1989;11(3):147-153.
- Koskinen T, Santavuori P, Sainio K, Lappi M, Kallio AK, Pihko H. Infantile onset spinocerebellar ataxia with sensory neuropathy: a new inherited disease. J Neurol Sci. 1994;121(1):50-56. [infantile onset spinocerebellar ataxia (IOSCA)]
I strongly feel that I am a privileged person. My dreams have more than come true. I wished to have four children and to become a medical doctor…I not only became a medical doctor but a clinician with most interesting and rewarding work. I have had the possibility to work with children, to meet real challenges, and to learn novel things every day. Once I thought that by the time of retirement, a person must be fully educated-luckily, that is not the case, and there are lots of things still to be discovered.Santavuori 1997
- Tyynelä J, Autti T, Haltia M, Mole SE. Pirkko Santavuori (1933-2004). J Child Neurol. 2004;19(6):465-470.
- Pihko H. Pirkko Santavuori 1933–2004. Neuromuscular Disorders 2004; 14: 284–285
- Bibliography. Santavuori, Pirkko. WorldCat Identities
- Hagberg B, Sourander P, Svennerholm L. Late infantile progressive encephalopathy with disturbed poly-unsaturated fat metabolism. Acta Paediatr Scand. 1968;57(6):495-499.
- Baumann RJ, Markesbery WR. Santavuori disease: diagnosis by leukocyte ultrastructure. Neurology. 1982;32(11):1277-1281.
- NEURONAL CEROID LIPOFUSCINOSIS, INFANTILE, INCLUDED. OMIM
the person behind the name